Press release
Recombinant Human Endostatin Market Key Players Analysis - Pfizer Inc., PeproTech, Inc., Onyx Pharmaceuticals, Inc., Novus Biologicals.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Recombinant Human Endostatin Market - (By Type (purity 95% and others) And By Application (medical care, scientific research and others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."According to the latest research by InsightAce Analytic, the Global Recombinant Human Endostatin Market is valued at US$ 133.3 Mn in 2023, and it is expected to reach US$ 249.4 Billion by 2031, with a CAGR of 8.3% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2597
Recombinant human endostatin is a bioengineered form of endostatin, a protein that the human body makes spontaneously and stops new blood vessels from growing. Genetic engineering is used to make the hybrid form, which is used in medicine. A number of factors are propelling the recombinant human endostatin market forward, including the rising incidence of cancer, developments in biotechnology, substantial investments in R&D, and the need for more precise cancer treatments. Furthermore, the market is anticipated to experience expansion during the forecast period due to government initiatives aimed at reducing the prices of anticancer medications and an increase in research and development activities focused on discovering potential uses of recombinant human endostatin. However, there are a number of factors that are limiting the market's potential for expansion, such as the high expense of development and the absence of authorized endostatin-based medications. In addition, the need for efficient cancer treatments is also anticipated to fuel the expansion of the recombinant human endostatin market.
List of Prominent Players in the Recombinant Human Endostatin Market:
• Thermo Fisher Scientific
• PeproTech
• Pfizer Inc.,
• Novus Biologicals,
• Biocon,
• Yantai Medgenn Ltd.,
• FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.,
• Onyx Pharmaceuticals, Inc.,
• Genexine, Inc.,
• Hetero.,
• Intas Pharmaceuticals Ltd.,
• Novartis AG.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
One of the main drivers propelling the recombinant human endostatin market is the ever-increasing demand for novel and efficient cancer treatments, as well as the worldwide rise in cancer incidence. The market for recombinant human endostatin has been growing due to the fact that manufacturing it has become more efficient and scalable thanks to advancements in genetic engineering and biotechnology. The safety and effectiveness of endostatin in preventing tumour growth and angiogenesis are being supported by several clinical trials and ongoing research, which is leading to its increased use in oncology. This industry is growing for a number of reasons, including more money going into cancer research and more enabling regulatory frameworks.
Challenges:
Several factors limit the expansion of the recombinant human endostatin industry. One of the main factors is a costly treatment option with limited accessibility and uptake due to its high production costs and sophisticated manufacturing methods. The introduction of new items to the market can be delayed due to strict regulatory requirements and lengthy approval processes. Another obstacle is the need for more knowledge about the advantages of recombinant human endostatin among both patients and healthcare providers. In addition, the presence of competing cancer therapies, new and old, can affect market penetration. Moreover, the broad use of recombinant human endostatin could be improved for these reasons when taken as a whole.
Regional Trends:
The North American recombinant human endostatin market is anticipated to report a major market share in revenue. It is projected to grow at a high CAGR in the near future because of the rising incidence of cancer, substantial investments in research and development, and well-developed healthcare systems, all of which are fueling the need for new and improved therapies. Besides, Europe has a substantial market share as a result of powerful healthcare systems, substantial funding for biotech research, and extensive backing from government programs. Moreover, market growth is further enhanced by the presence of top pharmaceutical companies and intensive clinical trials.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2597
Recent Developments:
• In June 2024, Thermo Fisher Scientific Inc announced the KingFisher™ PlasmidPro Maxi Processor, the only fully automated maxi-scale plasmid DNA (pDNA) purification machine. PlasmidPro automates small and maxi-scale purification and delivers high-purity plasmids without column preparation or intervention. This is the latest addition to the Thermo Scientific KingFisher instrument portfolio, which includes many plasmid DNA extraction tools to improve efficiency and consistency.
• In June 2024, Thermo Fisher Scientific Inc.'s PPD clinical research division expanded its central laboratory operations in Kentucky. This expansion is aimed at speeding up the delivery of medicines that work and are safe to patients by pharmaceutical and biotech companies.
Segmentation of Recombinant Human Endostatin Market-
By Type-
• Purity 95%
• Others
By Application-
• Medical Care
• Scientific Research
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2597
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Recombinant Human Endostatin Market Key Players Analysis - Pfizer Inc., PeproTech, Inc., Onyx Pharmaceuticals, Inc., Novus Biologicals. here
News-ID: 3775121 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd

Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
"Biocides Market" in terms of revenue was estimated to be worth $11.57 billion in 2023 and is poised to reach $16.83 billion by 2031, growing at a CAGR of 4.91% from 2024 to 2031, according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1637
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biocides Market are:
• Growing Awareness of Hygiene and…

Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Beneficial Insects Market Size, Share & Trends Analysis Report By Application (Crop protection, Crop production), Type (Predators, Parasitoids, Pathogens, and Pollinators), Crop Type (Fruits & Vegetables, Flowers & Ornamentals, and Grains & Pulses), Region, Market Outlook And Industry Analysis 2031"
The global Beneficial Insects market is estimated to reach over USD 2.18 billion by 2031, exhibiting…

Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
The global avocado puree market is estimated to reach over USD 755.03 million by 2031, exhibiting a CAGR of 5.18% during the forecast period.
Fresh avocados mashed, puréed, pressed, or sieved into a creamy slurry or paste consistency are used to make avocado purees. Avocado purees make mixed fruit drinks, infant food, and guacamole. Avocado puree market revenue is predicted to increase at a high CAGR, driven by millennials' phenomenal demand…

Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Lead Acid Battery Market Size, Share & Trends Analysis Report By Product (SLI and Micro-Hybrid Batteries), Type (Flooded, Enhanced Flooded, and VRLA), Customer Segment (OEM and Aftermarket), End User (Passenger Car, Light Commercial Vehicles, Heavy Commercial Vehicles, Two-Wheeler, and Three-Wheeler), and Application (Hybrid Vehicles, Electric Vehicles, Light Motor Vehicles, and Heavy Motor Vehicles)- Market…
More Releases for Recombinant
Global Recombinant Vaccines Market Segmentation, Business Analysis and Forecast …
Global Recombinant Vaccines Market Analysis 2022-2028 Report provides strategists, marketers and senior management with the critical information they need to assess the global Recombinant Vaccines Market as it emerges from the Covid-19 shut down. The impact of Coronavirus (COVID-19) on global market has reinforced many trends already shaping the industry pre COVID-19, There is a long-term trend towards the repositioning of players as entertainment providers on multiple platforms.
This study provides…
Recombinant Protein Market Size, Share | Recombinant Protein Industry Future Gro …
Global Recombinant Protein Market Report provides a detailed industry overview along with the analysis of Cost Structure, Supply Chain, Development Techniques, Retailers Analysis, Financial Support, business Strategies, Marketing Channels. Global Recombinant Protein Market research report provides a point-by-pointIn-Depth analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations,…
Human Recombinant Insulin Market Growth Analysis
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry…
United States Recombinant Vaccine Market Report
In this report, the United States Recombinant Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share…
Recombinant Proteins Market 2022 | Recombinant Proteins Market: Global Industry …
Recombinant proteins play an imperative role in treating various diseases, such as hemophilia. Majority of the recombinant proteins used are human proteins, in order to compensate the functional proteins in vivo defects by increasing the protein function in a body. This Research Report Insights analyzes the expansion of global recombinant protein market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.
The next…
Recombinant DNA Technology Market -
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have…